ライフサイエンスコーパス: Tc-99m

1 Tc-99m MAG3 is cleared from the kidney by tubular secret

2 Tc-99m MAG3 scintigraphy was performed in 49 patients at

3 Tc-99m sestamibi SPECT with dipyridamole stress is a goo

4 Tc-99m sestamibi was injected intravenously during the l

5 Tc-99m-HL91 uptake is sensitive for the early detection

6 -201 and Tc-99m tetrofosmin SPECT images; 2) Tc-99m tetrofosmin SPECT identified fewer reversible def

7 PECT) after the injection of technetium-99m (Tc-99m) sestamibi at rest.

8 infarct size as assessed by technetium-99m (Tc-99m) sestamibi perfusion tomographic imaging.

9 ectrocardiographically gated technetium-99m (Tc-99m) sestamibi single-photon emission computed tomogr

10 Technetium-99m (Tc-99m) sestamibi was injected before reperfusion therap

11 icular volumes during stress technetium-99m (Tc-99m) sestamibi/rest thallium-201 dual-isotope myocard

12 We compared dipyridamole technetium-99m (Tc-99m) tetrofosmin and thallium-201 (Tl-201) single-pho

13 cost-analysis of acute rest technetium-99m (Tc-99m) tetrofosmin single-photon emission computed tomo

14 computed tomographic (SPECT) technetium-99m (Tc-99m) tracer imaging in patients with stable symptoms,

15 ed to a critical shortage of technetium-99m (Tc-99m).

16 ium-99m diethylenetriamine pentaacetic acid (Tc-99m DTPA) clearance in the zone immediately distal to

17 ium-99m diethylenetriamine pentaacetic acid (Tc-99m DTPA) for imaging of the renal allograft.

18 Adenosine Tc-99m sestamibi SPECT is an efficient protocol with hig

19 quisition of rest thallium-201 and adenosine Tc-99m sestamibi and was visually analyzed in 20 segment

20 chemia as assessed by serial gated adenosine Tc-99m sestamibi myocardial perfusion tomography.

21 udy was to determine whether gated adenosine Tc-99m sestamibi single-photon emission computed tomogra

22 the study group who had undergone adenosine Tc-99m sestamibi myocardial perfusion SPECT, 130 had cor

23 The outcome measured was time to death after Tc 99m PYP imaging.

24 99mTc-labeled imaging agent, Tc-99m-HL91, developed as a putative hypoxic reagent, ha

25 h clinical suspicion of cardiac amyloidosis, Tc 99m PYP may be of diagnostic and prognostic importanc

26 mising model for evaluation of the analogous Tc-99m complexes as diagnostic imaging agents for breast

27 patients, 25 had defects on both Tl-201 and Tc-99m tetrofosmin SPECT images.

28 least one defect was seen on both Tl-201 and Tc-99m tetrofosmin SPECT images; 2) Tc-99m tetrofosmin S

29 h CAD underwent both dipyridamole Tl-201 and Tc-99m tetrofosmin SPECT.

30 Peptide oxorhenium complexes and Tc-99m complexes eluted closely upon HPLC analysis.

31 Echocardiography and Tc-99m sestamibi single photon emission computed tomogra

32 ylguanidine (MIBG), 111In-pentetreotide, and Tc-99m-methylene diphosphonate bone scintigraphy in 30 p

33 rom 21 centers underwent rest-stress PET and Tc-99m SPECT MPI.

34 ts positively correlated with serum TRAb and Tc-99m uptake (r=0.57, P=0.001 and r=0.74, P=0.001, resp

35 Objective: To assess Tc 99m PYP cardiac imaging as a diagnostic tool for ATTR

36 gression models correlating the plasma-based Tc-99m MAG3 clearance with the percentage uptake in the

37 jection was correlated with the plasma-based Tc-99m MAG3 clearances.

38 nalyzed, 102 had defects by Tl-201 and 92 by Tc-99m tetrofosmin (p = NS).

39 technetium-99m radiolabeled red blood cells (Tc-99m-RBC) for detection of liver hemangiomas is very h

40 as assessed using mortality, weight changes, Tc-99m annexin-V imaging, histopathology, and immunohist

41 le and partially reversible defects than did Tc-99m tetrofosmin (89 vs. 55, p = 0.002).

42 I underwent hospital admission and discharge Tc-99m-sestamibi tomographic imaging.

43 ected CAD who underwent rest Tl-201/exercise Tc-99m sestamibi dual-isotope myocardial perfusion SPECT

44 Exposure: Tc 99m PYP cardiac imaging for detection of ATTR cardiac

45 For Tc-99m sestamibi parathyroid imaging, early SPECT images

46 ible (30 +/- 4% for Tl-201 vs. 45 +/- 5% for Tc-99m tetrofosmin).

47 for Tl-201 vs. 42 +/- 4% [mean +/- SEM] for Tc-99m tetrofosmin, p = NS).

48 e addition of electrocardiographically gated Tc-99m sestamibi SPECT images to the reading of stress a

49 s the ability of electrocardiographic gating Tc-99m sestamibi single photon emission computed tomogra

50 utoradiography revealed significantly higher Tc-99m-HL91 contrast ratio at early and intermediate pha

51 yocardial segment with inducible ischemia in Tc-99m SPECT who underwent bone marrow biopsy and were a

52 yocardial segment with inducible ischemia in Tc-99m SPECT who underwent bone marrow biopsy and were a

53 5% confidence interval, 23.16-23.96) than in Tc-99m (12.92 mSv; 95% confidence interval, 12.55-13.40;

54 ges obtained up to 2 hours after intradermal Tc-99m sulfur colloid injection.

55 phy (DASE) and dipyridamole Technetium 99-m (Tc-99m) sestamibi single photon emission computed tomogr

56 ith technetium-99m mercaptoacetyltriglycine (Tc-99m MAG3) has made it the radiotracer of choice compa

57 In the development of novel Tc-99m-labeled tropane derivatives as dopamine transport

58 n a multicenter study and the association of Tc 99m PYP myocardial uptake with survival are unknown.

59 Main Outcomes and Measures: Retention of Tc 99m PYP in the heart was assessed using both a semiqu

60 o determine the quotients of accumulation of Tc-99m-RBC in hemangiomas and in normal liver parenchyma

61 a-based method to calculate the clearance of Tc-99m MAG3 was validated in a multicenter trial.

62 The percentage of the injected dose of Tc-99m MAG3 in the kidney at 1-2, 1.0-2.5, and 2-3 minut

63 ies have shown that myocardial extraction of Tc-99m tetrofosmin is lower than that of Tl-201 at high

64 dies obtained with 0.22-micron filtration of Tc-99m sulfur colloid in 41 patients (26 men, 15 women;

65 Electrocardiographic gating of Tc-99m sestamibi SPECT images permits assessment of regi

66 sitive nuclear images after the injection of Tc-99m DMP-444, the presence of platelet-rich thrombus w

67 tomography with injection of 20 to 30 mCi of Tc-99m sestamibi (n = 1215), interpreted in real time by

68 patients received an injection of 10 mCi of Tc-99m sestamibi the day of surgery.

69 0.22-micron filtration in the preparation of Tc-99m sulfur colloid substantially improves study quali

70 ere drawn to calculate the contrast ratio of Tc-99m-HL91 uptake between the ipsilateral and contralat

71 reversible defects seen on Tl-201 and not on Tc-99m tetrofosmin SPECT images were predominantly regio

72 the magnitude of reversible defects seen on Tc-99m tetrofosmin images was less, whereas fixed defect

73 significantly more severe on Tl-201 than on Tc-99m tetrofosmin (49 +/- 3% vs. 58 +/- 3%) SPECT image

74 01 detected 27 fixed defects in 12 patients, Tc-99m tetrofosmin identified 37 fixed defects in 14 pat

75 rs), and late (44 hrs) reoxygenation phases, Tc-99m-HL91 in vivo and ex vivo imaging and quantitative

76 A positive Tc-99m pyrophosphate study was defined by the presence o

77 enter studies, technetium 99m pyrophosphate (Tc 99m PYP) cardiac imaging noninvasively detects ATTR c

78 Abnormal rest Tc-99m tetrofosmin SPECT imaging accurately predicts acu

79 Results: Tc 99m PYP imaging of 171 participants (121 with ATTR ca

80 e 57.6 +/- 11.5 years) underwent gated SPECT Tc-99m sestamibi imaging (212 with exercise, 63 with dip

81 ve patients who underwent rest Tl-201/stress Tc-99m sestamibi gated single photon emission computed t

82 All patients underwent rest T1-201/stress Tc-99m sestamibi MPS and were followed up > or =1 year a

83 sease (CAD) who underwent rest Tl-201/stress Tc-99m sestamibi MPS, including 5,233 gated MPS studies

84 flurpiridaz PET and 1- or 2-day rest-stress Tc-99m-labeled SPECT and ICA.

85 ns and Relevance: In this multicenter study, Tc 99m PYP cardiac imaging conferred a high level of sen

86 Detection of a technetium Tc 99m-marked SLN before surgery was possible in all cas

87 monstrated colocalization between technetium Tc 99m tilmanocept (99mTc-tilmanocept) and CD206+ macrop

88 ordance rate of evaluable SLNs by technetium Tc 99m sulfur colloid and cRGDY-PEG-Cy5.5-nanoparticles

89 proportion of nodes identified by technetium Tc 99m sulfur colloid that were optically visualized by

90 sing standard technique guided by technetium Tc 99m.

91 atients received standard-of-care technetium Tc 99m sulfur colloid followed by a microdose administra

92 agreement over the reliability of technetium Tc 99m (99mTc)-labeled erythrocyte scintigraphy in the l

93 ause of the worldwide shortage of technetium Tc 99m, physicians are looking for nonradioactive dyes f

94 Medical record review or technetium Tc 99m pyrophosphate scintigraphy and reflex testing for

95 ous chloride TI 201 (thallium) or technetium Tc 99m sestamibi for detection and/or evaluation of coro

96 /systemic ratios of melphalan/TNF/technetium Tc 99m were 14.2/7/3.6.

97 nown ATTR-CM, contraindication to technetium Tc 99m pyrophosphate scanning, or other barriers to part

98 sidered a possible alternative to technetium Tc 99m.

99 88BV59, labeled with technetium Tc 99m (99mTc) (HumaSPECT-Tc), was injected intravenousl

100 Leakage was assessed with technetium Tc 99m radiolabeled human serum albumin, and a pharmacok

101 erative localization of SLNs with technetium Tc 99m sulfur colloid was followed by particle dose-esca

102 operative lymphoscintigraphy with technetium Tc 99m.

103 We hypothesized that Tc-99m-HL91 is sensitive for the early identification of

104 egree of transient ischemic dilation and the Tc-99m sestamibi defect extent, the latter assessed by s

105 e-center study, the use of Tl-201 during the Tc-99m shortage was associated with an increase in downs

106 stand the impact of using Tl-201 (during the Tc-99m shortage) on downstream resource utilization.

107 All of the Tc-99m complexes, with the exception of 16, displayed go

108 t territory was assessed by the nadir of the Tc-99m sestamibi count-profile curve.

109 Biological evaluation of the Tc-99m-labeled complexes 13-16 as central nervous system

110 and after (POST_Tc-99m [1505 patients]) the Tc-99m shortage.

111 l-201 cohort (639 [21.4%] patients) than the Tc-99m cohort (537 [12.1%] patients; P<0.001).

112 n the DURING_Tl-201 cohort compared with the Tc-99m cohort ($90.97; 95% confidence interval, 83.42-98

113 d for cardiac amyloidosis and also underwent Tc 99m PYP cardiac imaging.

114 l ischemia and a nondiagnostic ECG underwent Tc-99m tetrofosmin SPECT during or within 6 h of symptom

115 Forty-seven adult patients underwent Tc-99m sestamibi SPECT.

116 ided a short-term solution to the unexpected Tc-99m shortage, long-term cost-effective solutions shou

117 reports in English on risk assessment using Tc-99m perfusion tracers.

118 rom the kidney by tubular secretion, whereas Tc-99m DTPA is cleared by glomerular filtration.

119 hy control subjects (with Xe-133 in 15, with Tc-99m HMPAO in 14) were available.

120 oid gland was calculated and correlated with Tc-99m uptake and thyroid function tests of the patients

121 Perfusion imaging with Tc-99m-sestamibi can identify post-MI patients at hospit

122 PET) myocardial perfusion imaging (MPI) with Tc-99m single-photon emission computed tomography (SPECT

123 Brain mapping studies were preformed with Tc-99m bicisate SPECT, and activation-induced changes we

124 d 1 hour after in vivo labeling of RBCs with Tc-99m.

125 nly evaluate split renal function (SRF) with Tc-99m-mercapto-acetyltriglycin (MAG3) scintigraphy in l

126 aphy, or SPECT) perfusion imaging study with Tc-99m sestamibi.

127 ly labeled (91-98% radiochemical yield) with Tc-99m in the presence of tricine and SnCl(2) with high